Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$580 Sell
63
-9
-13% -$82 ﹤0.01% 4190
2026
Q2
$502 Buy
+72
New +$401 ﹤0.01% 3982
2026
Q1
– Sell
-2,708
Closed -$12.3K – 4229
2025
Q4
$12.3K Buy
2,708
+2,469
+1,033% +$12.7K ﹤0.01% 2877
2025
Q3
$1.47K Sell
239
-141
-37% -$892 ﹤0.01% 3526
2025
Q2
$2.46K Sell
380
-1,152
-75% -$6.21K ﹤0.01% 3347
2025
Q1
$8.13K Sell
1,532
-1,033
-40% -$7.06K ﹤0.01% 2852
2024
Q4
$21.5K Buy
2,565
+1,263
+97% +$9.75K ﹤0.01% 2230
2024
Q3
$10.3K Buy
1,302
+636
+95% +$5.72K ﹤0.01% 2446
2024
Q2
$6.86K Sell
666
-570
-46% -$6.17K ﹤0.01% 2428
2024
Q1
$15.5K Buy
1,236
+1,000
+424% +$12.9K ﹤0.01% 1811
2023
Q4
$3.25K Buy
+236
New +$3.3K ﹤0.01% 2410

Other funds holding TBI

GAMMA Investing's TBI Position: Q3 2026 in Review

GAMMA Investing reduced its Trueblue (TBI) stake by 13% in Q3 2026, selling an estimated $82 and leaving 63 shares worth $580. The position accounts for ﹤0.01% of the portfolio, ranked #4190.

GAMMA Investing first reported a position in TBI in Q4 2023 and has held it in 11 quarters since. The position peaked at $21.5K in Q4 2024. 4 funds tracked by Wall St. Rank hold TBI as of Q3 2026.

  • GAMMA Investing held 63 shares of Trueblue worth $580 as of Q3 2026.
  • GAMMA Investing sold 9 Trueblue shares in Q3 2026, an estimated $82.
  • Trueblue made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4190 holding.
  • GAMMA Investing first reported a position in Trueblue in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Trueblue position peaked at $21.5K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Trueblue as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.